No Data
No Data
Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference
H.C. Wainwright Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $45
Companies Like Oruka Therapeutics (NASDAQ:ORKA) Are In A Position To Invest In Growth
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Oruka Therapeutics Reports Strong 2024 Financial Results